Publication:
Usage of bioactivated PCL nanofiber as a fluoxetine capturing matrix in milk

Simple item page
dc.contributor.authorAKBAY, TUĞBA
dc.contributor.authorsTaslak, Hava Dudu; Gokmen, Begum Gurel; Ozcan, Ozan; Tunali-Akbay, Tugba
dc.date.accessioned2022-03-12T22:40:18Z
dc.date.accessioned2026-01-11T19:22:35Z
dc.date.available2022-03-12T22:40:18Z
dc.date.issued2020
dc.description.abstractIn this study, for the first time, polycaprolactone (PCL) nanofiber matrix was bioactivated for the removal of fluoxetine from milk. Bioactivated nanofiber was prepared by immobilizing fluoxetine antibody on PCL nanofiber matrix. The fluoxetine removal efficiency of bioactivated nanofiber in milk was found to be approximately 93.6%. This removal did not significantly change the biochemical composition of milk. In conclusion, as a novel product, bioactivated nanofibrous PCL matrix can be used for the removal of drugs or unwanted chemicals from breast milk or from other fluids.
dc.identifier.doi10.1080/01496395.2019.1574829
dc.identifier.eissn1520-5754
dc.identifier.issn0149-6395
dc.identifier.urihttps://hdl.handle.net/11424/235935
dc.identifier.wosWOS:000526702000003
dc.language.isoeng
dc.publisherTAYLOR & FRANCIS INC
dc.relation.ispartofSEPARATION SCIENCE AND TECHNOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectFluoxetine
dc.subjectpolycaprolactone
dc.subjectnanofiber
dc.subjectmilk
dc.subjectANTIBODIES
dc.subjectIMMOBILIZATION
dc.subjectDELIVERY
dc.subjectDRUG
dc.titleUsage of bioactivated PCL nanofiber as a fluoxetine capturing matrix in milk
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage834
oaire.citation.issue5
oaire.citation.startPage828
oaire.citation.titleSEPARATION SCIENCE AND TECHNOLOGY
oaire.citation.volume55

Files

Collections

Araştırma Çıktıları